Full Name
Liang Xu
(not current staff)
Variants
Xu Liang
 
 
 
Email
csixl@nus.edu.sg
 

Publications

Results 1-9 of 9 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12018Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progressionJiang Y. ; Jiang Y.-Y. ; Xie J.-J.; Mayakonda A. ; Hazawa M. ; Chen L.; Xiao J.-F. ; Li C.-Q.; Huang M.-L.; Ding L.-W. ; Sun Q.-Y. ; Xu L. ; Kanojia D. ; Jeitany M. ; Deng J.-W. ; Liao L.-D.; Soukiasian H.J.; Berman B.P.; Hao J.-J.; Xu L.-Y.; Li E.-M.; Wang M.-R.; Bi X.-G.; Lin D.-C. ; Koeffler H.P. 
22018Functional genome-wide screening identifies targets and pathways sensitizing pancreatic cancer cells to dasatinibChien W. ; Sudo M. ; Ding L.-W. ; Sun Q.-Y. ; Wuensche P.; Lee K.L. ; Hattori N.; Garg M. ; Xu L. ; Zheng Y.; Gery S.; Wongphayak S. ; Yang H. ; Baloglu E.; Shacham S.; Kauffman M.; Mori S. ; Phillip Koeffler H.
32019LNK suppresses interferon signaling in melanomaDing, L.-W. ; Sun, Q.-Y. ; Edwards, J.J.; Fernández, L.T.; Ran, X.-B.; Zhou, S.-Q. ; Scolyer, R.A.; Wilmott, J.S.; Thompson, J.F.; Doan, N.; Said, J.W.; Venkatachalam, N.; Xiao, J.-F. ; Loh, X.-Y.; Pein, M.; Xu, L. ; Mullins, D.W.; Yang, H. ; Lin, D.-C.; Koeffler, H.P. 
42020Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitorLim, S.-L.; Xu, L. ; Han, B.-C.; Shyamsunder, P. ; Chng, W.-J. ; Phillip Koeffler, H. 
52017Mutational profiling of acute lymphoblastic leukemia with testicular relapseDing, L.-W ; Sun, Q.-Y ; Mayakonda, A ; Tan, K.-T ; Chien, W ; Lin, D.-C ; Jiang, Y.-Y ; Xu, L ; Garg, M ; Lao, Z.-T ; Lill, M.; Yang, H ; Yeoh, A.E.J ; Koeffler, H.P 
62018Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines 11 Medical and Health Sciences 1107 ImmunologyTan, K.-T ; Ding, L.-W ; Sun, Q.-Y ; Lao, Z.-T ; Chien, W ; Ren, X; Xiao, J.-F ; Loh, X.Y ; Xu, L ; Lill, M; Mayakonda, A ; Lin, D.-C; Yang, H ; Koeffler, H.P 
72019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
82015SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathwaySun Qiao Yang ; Ding Ling Wen ; Xiao Jin Fen; Chien Wen Wen ; Lim Su Lin ; Hattori Norimichi; Goodglick Lee; Chia David; Mah Vei; Alavi Mohammad; Kim S.R.,; Doan N.B.; Said J.W; Loh Xin Yi ; Xu Liang ; Liu Li Zhen ; Yang Henry ; Takahide Hayano ; Shi Shuo; Xie Dong; Lin De Chen ; Koeffler Philip H. 
915-Mar-2023Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyRan, XB; Ding, LW ; Sun, QY ; Yang, H ; Said, JW; Zhentang, L ; Madan, V ; Dakle, P ; Xiao, JF; Loh, X ; Li, Y ; Xu, L ; Xiang, XQ; Wang, LZ; Goh, BC ; Lin, DC; Chng, WJ ; Tan, SY ; Jha, S ; Koeffler, HP